Share

Join our free Webinar: Bringing Asthma Care into the 21st Century

accreditation
0:00
play article
Subscribers can listen to this article
(Image: Getty Images)
(Image: Getty Images)

Take the first steps to better asthma treatment in 2022. 

Asthma affects as many as 339 million adults and children worldwide. Too many people still die from this respiratory condition despite the widespread availability of evidence-based medications. And although there is no cure, with good asthma care, asthmatics can enjoy a full, healthy and happy life.

Over time the best practice approach to asthma management has completely changed, and in the last 30 years, studies have shown that the old way of doing things can actually cause more asthma attacks.

AstraZeneca will host a free webinar on News24 at 19h00 on Tuesday 31 May 2022, offering asthmatics, parents, and caregivers insight into the latest developments in asthma treatment and how to better manage the disease for greater control. 

Over-reliance on reliever pumps linked to increased risk of asthma attacks 

Regardless if your asthma is mild, moderate or severe, at the heart of it is the need to reduce inflammation, says Doctor Marlin McKay, who practices at the Goldman Medical Centre. 

Mild asthma doesn’t preclude you from having an asthma attack. The risk is equally high regardless of disease severity, adherence to treatment, or level of control.

"Asthma patients frequently underuse anti-inflammatory maintenance therapy and instead, over-rely on SABA reliever therapy which provides rapid and temporary relief. The problem with this approach is it can mask the worsening of symptoms and actually increases the risk of asthma attacks," says McKay. 

New global guidelines reveal big changes in asthma treatment

According to Dr Khomotso Mashilane, Medical Director: African Cluster at AstraZeneca, evidence suggests a world-wide challenge of SABA overuse and over-reliance. 

Following the paradigm shifts and updates to the global asthma management recommendations, AstraZeneca developed the Break Over-Reliance public health campaign to inform and educate patients, health professionals and policymakers. 

"As an established leader in respiratory care, we are committed to working with the respiratory community to provide tools that will help improve asthma control and aim to eliminate preventable asthma attacks for the millions of asthma patients in South Africa," says Mashilane.

Hosted by Dr Michael Mol, the webinar will address a range of topics, which include: 

  • Revised global asthma treatment guidelines
  • Updates locally to the South African Thoracic Society guidelines
  • Mild asthmatics are just as at risk of asthma attacks and can be hospitalised
  • The same approach is followed for the treatment of mild and serious asthma – with reducing chronic inflammation at the crux of control

Don't miss out on this opportunity to hear from leading experts as they share their knowledge and weigh in on the asthma new treatment guidelines. 

The free AstraZeneca Bringing Asthma Care into the 21st Century - New Approaches for Better Control webinar will be available and published on News24 at 19h00 on Tuesday 31 May 2022.

To register for a reminder, sign up to our mailing list below:

 

This post was sponsored by AstraZeneca and produced by Adspace Studio.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Voting Booth
Should the Proteas pick Faf du Plessis for the T20 World Cup in West Indies and the United States in June?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes! Faf still has a lot to give ...
68% - 2099 votes
No! It's time to move on ...
32% - 1010 votes
Vote
Rand - Dollar
18.56
+0.2%
Rand - Pound
23.27
+0.2%
Rand - Euro
19.91
+0.2%
Rand - Aus dollar
12.19
-0.3%
Rand - Yen
0.12
+0.0%
Platinum
958.60
-0.4%
Palladium
937.50
-1.8%
Gold
2,301.23
-0.8%
Silver
26.63
-0.0%
Brent Crude
83.44
-3.5%
Top 40
69,944
+0.0%
All Share
76,047
-0.0%
Resource 10
60,380
-1.5%
Industrial 25
105,857
+0.8%
Financial 15
16,588
-0.0%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE